Use of Myoinositol in PCOS

Nov 15, 2025

Authors: Saghar Salehpour, Sedigheh Hosseini and Zahra Zarisfi

EGOI-PCOS survey on the prevalence of respiratory disorders associated with polycystic ovary syndrome

Nov 7, 2025

Authors: Mario Montanino Oliva, Maurizio Nordio, Orietta Picconi, Giuseppina Porcaro

From Ovarian to Endocrine-Metabolic Roots: Aligning PCOS Nomenclature with Pathophysiology

Oct 10, 2025

Authors: Unfer, V.

PCOS phenotype focus: phenotype D under the magnifying glass

Sep 26, 2025

Authors: Myers SH, Montanino Oliva M, Nordio M, Unfer V.

Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)

Sep 11, 2025

Authors: Geraci Giovanna , Riccio Carmine , Oliva Fabrizio , Gabrielli Domenico , Colivicchi Furio , Grimaldi Massimo , Facchinetti Fabio , Unfer Vittorio

Effect of 40:1 myo-inositol/D-chiro-inositol treatment on serum asprosin levels in polycystic ovary syndrome: a prospective randomized pilot study

Sep 2, 2025

Authors: Ozay OE, Ozay Y, Edebal O, Calcagno M, Ozay AC.